Revance Therapeutics shares owned by Envestnet Asset Management
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Envestnet Asset Management
from 13F filings
Historical chart of Envestnet Asset Management investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Envestnet Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $220k | 19k | 11.47 |
| 2023-06-30 | $646k | 26k | 25.31 |
| 2023-03-31 | $624k | 19k | 32.21 |
| 2022-12-31 | $532k | 29k | 18.46 |
| 2022-09-30 | $386k | 14k | 26.97 |
| 2022-06-30 | $147k | 11k | 13.78 |
| 2022-03-31 | $245k | 13k | 19.53 |
| 2021-12-31 | $331k | 20k | 16.31 |
| 2021-09-30 | $989k | 36k | 27.87 |
| 2021-06-30 | $1.0M | 35k | 29.63 |
| 2021-03-31 | $338k | 12k | 27.98 |
| 2020-12-31 | $272k | 9.6k | 28.38 |
| 2020-09-30 | $272k | 11k | 25.15 |
| 2020-06-30 | $255k | 11k | 24.39 |
| 2020-03-31 | $160k | 11k | 14.78 |
| 2019-12-31 | $199k | 12k | 16.23 |
| 2017-06-30 | $1.0k | 27 | 37.04 |
| 2017-03-31 | $1.0k | 27 | 37.04 |
| 2016-12-31 | $1.0k | 27 | 37.04 |
More positions owned by Envestnet Asset Management
View all positions for Envestnet Asset Management